Covestor’s Bioventus BVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$79K Buy
5,808
+1,182
+26% +$15.6K 0.05% 481
2026
Q2
$44K Buy
4,626
+430
+10% +$4.11K 0.03% 856
2026
Q1
$38K Sell
4,196
-2,249
-35% -$18.9K 0.03% 845
2025
Q4
$48K Sell
6,445
-3,506
-35% -$25.2K 0.03% 919
2025
Q3
$67K Buy
9,951
+2,176
+28% +$15.1K 0.04% 770
2025
Q2
$51K Buy
7,775
+2,389
+44% +$16.9K 0.03% 882
2025
Q1
$49K Sell
5,386
-22
-0.4% -$220 0.03% 849
2024
Q4
$57K Sell
5,408
-376
-7% -$4.45K 0.04% 799
2024
Q3
$69K Buy
+5,784
New +$50K 0.04% 723
2023
Q1
– Sell
-459
Closed -$1K – 2045
2022
Q4
$1K Sell
459
-25
-5% -$109 ﹤0.01% 1839
2022
Q3
$3K Buy
+484
New +$3.79K ﹤0.01% 1602

Other funds holding BVS

Covestor's BVS Position: Q3 2026 in Review

Covestor increased its Bioventus (BVS) stake by 26% in Q3 2026, buying an estimated $15.6K and bringing the position to 5,808 shares worth $79K. The position accounts for 0.05% of the portfolio, ranked #481.

Covestor first reported a position in BVS in Q3 2022 and has held it in 11 quarters since. 127 funds tracked by Wall St. Rank hold BVS as of Q3 2026.

  • Covestor held 5,808 shares of Bioventus worth $79K as of Q3 2026.
  • Covestor bought 1,182 Bioventus shares in Q3 2026, an estimated $15.6K.
  • Bioventus made up 0.05% of Covestor's portfolio in Q3 2026, its #481 holding.
  • Covestor first reported a position in Bioventus in Q3 2022 and has held it in 11 quarters since.
  • 127 funds tracked by Wall St. Rank held Bioventus as of Q3 2026.

Based on Covestor's 13F filing for Q3 2026, filed 30 Oct 2026.